New drug may let kids with hemophilia play sports safer
NCT ID NCT05022459
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether Emicizumab, a newer drug, prevents bleeding during sports better than standard Factor VIII in children with moderate to severe hemophilia A. About 72 kids aged 6 to 19 who already play sports and take one of these drugs will be followed. The goal is to see which drug leads to fewer bleeds during physical activity.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Emicizumab and Factor VIII
What this could lead to
If Emicizumab works better, it could allow kids with hemophilia A to play sports with fewer bleeds and less frequent injections.
What could go wrong
This is a small, early-stage study (72 participants) comparing two existing drugs, so results may not apply to all patients. Bleeding risk remains.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Arkansas Children's Hospital
RECRUITINGLittle Rock, Arkansas, 72202, United States
Contact Email: •••••@•••••
-
Boston Children's Hospital
RECRUITINGBoston, Massachusetts, 02215, United States
Contact Email: •••••@•••••
-
Children's Hospital of Michigan
RECRUITINGDetroit, Michigan, 48201, United States
Contact Email: •••••@•••••
-
Cincinnati Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 45229, United States
Contact Email: •••••@•••••
-
Indiana Hemophilia & Thrombosis Center
RECRUITINGIndianapolis, Indiana, 46260, United States
Contact Email: •••••@•••••
-
Johns Hopkins All Children's Hospital
RECRUITINGSt. Petersburg, Florida, 33701, United States
Contact Email: •••••@•••••
-
Oklahoma Center for Bleeding and Clotting Disorders
RECRUITINGOklahoma City, Oklahoma, 73104, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Rady Children's Hospital
RECRUITINGSan Diego, California, 92123, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Stanford University
RECRUITINGPalo Alto, California, 94304, United States
Contact Email: •••••@•••••